Leerink Partners Downgrades Spruce Biosciences, Inc. (SPRB) to Market Perform

March 14, 2024 6:19 AM

Leerink Partners analyst Joseph Schwartz downgraded Spruce Biosciences, Inc. (NASDAQ: SPRB) from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found